Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Summary

The main objective is to assess the feasibility of treatment by injecting botulinum toxin A into the hand or foot of patients with signs of critical ischemia secondary to Buerger's disease. The injection of botulinum toxin A is carried out at the end of a single session during an hospitalization. Furthermore, tolerance and effects on the disease are evaluated at 1, 3 and 6 months post injections.

Timeline

Start

2027-01-01

Primary completion

2028-02

Completion

2028-02

Drugs

Indications